AEGiS-UNAIDS: AIDS focus at U.S. Evangelical Summit UNAIDSImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to UNAIDS main menu
DonateNow
Print this Article


AIDS focus at U.S. Evangelical Summit

UNAIDS - November 29, 2007


UNAIDS Executive Director Dr. Peter Piot spoke today at the Saddleback Church Global AIDS Summit in Lake Forest, California. Dr Piot noted the unique and important role in the global AIDS response of religious groups of all kinds, which provide HIV treatment, care and support in some of the remotest parts of the world.

He called on religious leaders to scale up efforts to promote tolerance: to denounce discrimination and violence based on gender, sexual orientation or social status, and to eradicate the stigma around AIDS. He encouraged them to reach out to groups who are marginalized by society and as a result at greater risk of HIV infection.

"A quarter century into the AIDS response, it is time to take stock of the progress we've made, and consolidate and scale up what's working," said Dr Piot. "It is also time to recognize that all of us can, and must, do more, if we are to get ahead of the epidemic."

Leadership was an important theme of the summit, and was the focus of speeches from Dr Piot and United States Global AIDS Coordinator Ambassador Mark Dybul who spoke in a session called 'Excellence in Global Leadership'. Also speaking on the topic were leaders from the Organization of African First Ladies Against AIDS - Her Excellency, Mrs. Jeannette Kagame, First Lady of Rwanda and Her Excellency, Mrs. Maureen Mwanawasa, First Lady of Zambia.

The Saddleback Summit was organized by Saddleback founder Church Rick Warren and his wife Kay Warren, Executive Director of the church's AIDS initiative, as an avenue for attendees to learn more about AIDS and coordinate their efforts to address the disease. The summit is taking place from November 28-30. A youth summit is scheduled to follow on December 1.


071129
UN071114


Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .